These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 1883484)
1. The effect of anti-oestrogens on cell growth and progesterone receptor concentration in human endometrial cancer cells (Ishikawa). Jamil A; Croxtall JD; White JO J Mol Endocrinol; 1991 Jun; 6(3):215-21. PubMed ID: 1883484 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Gong Y; Ballejo G; Murphy LC; Murphy LJ Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100 [TBL] [Abstract][Full Text] [Related]
3. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Lykkesfeldt AE; Madsen MW; Briand P Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264 [TBL] [Abstract][Full Text] [Related]
4. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions. van den Berg HW; Martin J; Lynch M Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575 [TBL] [Abstract][Full Text] [Related]
5. Tamoxifen-stimulated growth of human endometrial carcinoma. Jordan VC; Gottardis MM; Satyaswaroop PG Ann N Y Acad Sci; 1991; 622():439-46. PubMed ID: 1905895 [TBL] [Abstract][Full Text] [Related]
6. Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells. Wakeling AE; Newboult E; Peters SW J Mol Endocrinol; 1989 May; 2(3):225-34. PubMed ID: 2665780 [TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells. Coopman P; Garcia M; BrĂ¼nner N; Derocq D; Clarke R; Rochefort H Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314 [TBL] [Abstract][Full Text] [Related]
8. Biological responses of ICI 164,384 and other anti-estrogens in vaginal and uterine cells of fetal guinea pig in culture. Chetrite G; Pasqualini JR Acta Endocrinol (Copenh); 1991 Oct; 125(4):401-8. PubMed ID: 1957558 [TBL] [Abstract][Full Text] [Related]
9. Comparative studies on the effects of steroidal and nonsteroidal oestrogen antagonists on the proliferation of human breast cancer cells. Wakeling AE J Steroid Biochem; 1989; 34(1-6):183-8. PubMed ID: 2696844 [TBL] [Abstract][Full Text] [Related]
10. Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model. Langdon SP; Crew AJ; Ritchie AA; Muir M; Wakeling A; Smyth JF; Miller WR Eur J Cancer; 1994; 30A(5):682-6. PubMed ID: 8080688 [TBL] [Abstract][Full Text] [Related]
11. Biological response of the anti-estrogen ICI 164,384 in human hormone-dependent and hormone-independent mammary cancer cell lines. Pasqualini JR; Gelly C Cancer Lett; 1990 Apr; 50(2):133-9. PubMed ID: 2328482 [TBL] [Abstract][Full Text] [Related]
12. Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells. de Cupis A; Noonan D; Pirani P; Ferrera A; Clerico L; Favoni RE Br J Pharmacol; 1995 Nov; 116(5):2391-400. PubMed ID: 8581274 [TBL] [Abstract][Full Text] [Related]
13. Target specificity of selective estrogen receptor modulators within human endometrial cancer cells. Bramlett KS; Burris TP J Steroid Biochem Mol Biol; 2003 Jul; 86(1):27-34. PubMed ID: 12943742 [TBL] [Abstract][Full Text] [Related]
14. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines. Coradini D; Biffi A; Pirronello E; Di Fronzo G Anticancer Res; 1995; 15(6B):2557-61. PubMed ID: 8669823 [TBL] [Abstract][Full Text] [Related]
15. Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro. DeFriend DJ; Anderson E; Bell J; Wilks DP; West CM; Mansel RE; Howell A Br J Cancer; 1994 Aug; 70(2):204-11. PubMed ID: 8054267 [TBL] [Abstract][Full Text] [Related]
16. [Biological action of the antiestrogen ICI 164.384 in the MCF-7 mammary cancer cell line]. Gelly C; Pasqualini JR Pathol Biol (Paris); 1989 Sep; 37(7):824-6. PubMed ID: 2631031 [TBL] [Abstract][Full Text] [Related]
17. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen. BrĂ¼nner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017 [TBL] [Abstract][Full Text] [Related]
18. Neuronal signals are required for estrogen-mediated induction of progesterone receptor in cultured rat Schwann cells. Thi AD; Jung-Testas I; Baulieu EE J Steroid Biochem Mol Biol; 1998 Nov; 67(3):201-11. PubMed ID: 9879979 [TBL] [Abstract][Full Text] [Related]
19. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment. Lykkesfeldt AE; Larsen SS; Briand P Int J Cancer; 1995 May; 61(4):529-34. PubMed ID: 7759159 [TBL] [Abstract][Full Text] [Related]
20. Both estradiol and tamoxifen decrease proliferation and invasiveness of cancer cells transfected with a mutated estrogen receptor. Garcia M; Derocq D; Platet N; Bonnet S; Brouillet JP; Touitou I; Rochefort H J Steroid Biochem Mol Biol; 1997 Apr; 61(1-2):11-7. PubMed ID: 9328205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]